Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Pension (2020 - 2025)

Historic Pension for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $527825.0.

  • Gain Therapeutics' Pension rose 6327.88% to $527825.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $527825.0, marking a year-over-year increase of 6327.88%. This contributed to the annual value of $443623.0 for FY2024, which is 4428.92% up from last year.
  • Gain Therapeutics' Pension amounted to $527825.0 in Q3 2025, which was up 6327.88% from $522676.0 recorded in Q2 2025.
  • Gain Therapeutics' 5-year Pension high stood at $527825.0 for Q3 2025, and its period low was $157580.0 during Q4 2022.
  • In the last 5 years, Gain Therapeutics' Pension had a median value of $307454.0 in 2023 and averaged $314115.5.
  • As far as peak fluctuations go, Gain Therapeutics' Pension tumbled by 5751.2% in 2023, and later skyrocketed by 10139.68% in 2024.
  • Quarter analysis of 5 years shows Gain Therapeutics' Pension stood at $329458.0 in 2021, then plummeted by 52.17% to $157580.0 in 2022, then soared by 95.11% to $307454.0 in 2023, then soared by 44.29% to $443623.0 in 2024, then grew by 18.98% to $527825.0 in 2025.
  • Its last three reported values are $527825.0 in Q3 2025, $522676.0 for Q2 2025, and $470856.0 during Q1 2025.